Lathrop & Gage Welcomes Two IP Attorneys
By Lawdragon News | May 9, 2017 | Press Releases, Lathrop & Gage News
BOSTON (May 8, 2017) – Lathrop & Gage today announced the addition of Of Counsel attorneys Gordon Moriartyand David E. Johnson, Ph.D. to the firm’s Intellectual Property practice in Boston.
Both have extensive experience in Intellectual Property, each with a different focus. Moriarty assists clients with patent matters in the fields of electrical and mechanical engineering as well as with trademark matters. Johnson’s focus is primarily on biotechnology and life sciences-related matters.
About the attorneys:
Gordon Moriarty has over 25 years of experience in the protection of intellectual property. He prosecutes patent applications across a wide array of technologies with extensive experience in computer networks and hardware, medical and laboratory analytical equipment, electro-optical measurement apparatus, environmental monitoring and control systems, micro-mechanical devices, and software. He also has considerable experience in successfully prosecuting trademark portfolios in the U.S. and abroad. With a comprehensive engineering and technological background, he proactively advises on and manages clients’ intellectual property assets while providing guidance during the prosecution and licensing of patents and trademarks.
Prior to pursuing a legal career, Mr. Moriarty was an electrical engineer for a large, international defense electronics company where he was involved in software development, digital system design, and radar system testing. His legal career began during law school where he served as a law clerk and technology specialist. He earned his juris doctor from Northeastern University School of Law.
Dr. David Johnson draws on 20 plus years of experience in his intellectual property practice, focusing primarily on biotechnology and life sciences-related matters. He advises a wide array of clients, ranging from multinational pharmaceutical companies to start-ups, on the development of worldwide patent portfolio prosecution strategies for products in clinical development. His experience in transactional matters includes evaluating third party in-licensing and acquisition opportunities, due diligence review, product and technology clearances, and licensing negotiations. Particular areas of expertise include nucleic acid and polypeptide based therapeutics and diagnostics, as well as formulations.
He earned his juris doctor and his Ph.D. from the University of Colorado, and a B.A. in Biology from Princeton University.
About Lathrop & Gage:
Lathrop & Gage has 300 attorneys nationwide serving clients in the areas of litigation, intellectual property and business. Chambers USA ranks Lathrop & Gage’s corporate, environmental, labor and employment, litigation and real estate practices among the best in their regions. For more information, visit www.lathropgage.com.
